Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Signaling pathways in obesity: mechanisms and therapeutic interventions
X Wen, B Zhang, B Wu, H ** cardiovascular disease, with heart failure (HF) …
Pharmacological approaches to the prevention of type 2 diabetes mellitus
About 1 in 10 adults worldwide are estimated to have diabetes mellitus. They are at risk of
develo** life-threatening complications resulting in reduced quality of life, increased …
develo** life-threatening complications resulting in reduced quality of life, increased …
Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: an exploratory analysis from DAPA-HF
SE Inzucchi, KF Docherty, L Køber… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE The sodium–glucose cotransporter 2 inhibitor dapagliflozin reduced the risk of
cardiovascular mortality and worsening heart failure in the Dapagliflozin and Prevention of …
cardiovascular mortality and worsening heart failure in the Dapagliflozin and Prevention of …
Pharmacological support for the treatment of obesity—present and future
M Kosmalski, K Deska, B Bąk, M Różycka-Kosmalska… - Healthcare, 2023 - mdpi.com
Obesity is a growing civilization problem, associated with a number of negative health
consequences affecting almost all tissues and organs. Currently, obesity treatment includes …
consequences affecting almost all tissues and organs. Currently, obesity treatment includes …